Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak
M. Lanspa (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), S. Callahan (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Collingridge (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), D. Blagev (Salt Lake City, United States of America)
Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lanspa (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), S. Callahan (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Collingridge (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), D. Blagev (Salt Lake City, United States of America). Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak. 4388
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: